(VIANEWS) – Shares of Alnylam Pharmaceuticals (NASDAQ Composite: ALNY) rose 5.06% to $181.62 at 14:22 EST on Thursday, after three consecutive sessions in a row of gains. NASDAQ Composite is rising 0.6% to $15,907.15, after five sequential sessions in a row of gains. This seems, as yet, a somewhat positive trend trading session today.
Today’s last reported volume for Alnylam Pharmaceuticals is 486465 which is 21.29% below its average volume of 618087.
Alnylam Pharmaceuticals’s Sales
Alnylam Pharmaceuticals’s sales growth is 74.6% for the ongoing quarter and 46.7% for the next. The company’s growth estimates for the ongoing quarter and the next is 28% and 23.9%, respectively.
Alnylam Pharmaceuticals’s last week, last month’s, and last quarter’s current volatility was a positive 1.14%, a negative 0.81%, and a positive 2.11%, respectively.
Alnylam Pharmaceuticals’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 2.22% (last week), 2.20% (last month), and 2.11% (last quarter), respectively.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,
Alnylam Pharmaceuticals’s stock is considered to be oversold (<=20).
More news about Alnylam Pharmaceuticals (ALNY).